You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline characteristics in patients with and without confirmed CDI diagnosis.

From: Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection

  N (%) or median (IQR)
Variable CDI-positive (n =9) CDI-negative (n = 6)
Age (years) 62 (50-86) 64 (59-65)
Peak creatinine (μmol/L)   
< 100 8 (89) 6 (100)
100-199 0 0
≥200 1 (11) 0
Peak leukocyte count × 109/L < 10.0 0 1 (17)
10.0 - 19.9 2 (22) 2 (22)
≥20.0 7 (78) 3 (50)
Number of stools/day 4 (0-6) 5 (3-6)
Fever (first 48 hours) 3 (33) 5 (83)
Ileus 1 (11) 0
Initially prescribed dosage   
125 mg 5 (56) 4 (67)
250 mg 3 (33) 1 (17)
500 mg 1 (11) 1 (17)
Days of treatment 6 (5-15) 5 (4-10)